Warning letters, 483s, Recalls, Import Alerts, Audit observations
EMA, the European Commission (EC) and the Heads of Medicines Agencies (HMA) are phasing out
Catalent USFDA 483 /Bloomington (FEI :3005949964)/ Inspection Dates: May 4-12, 2023 / Inspectors: Wayne Scifert,
Accord USA has initiated recall of multiple lots of Atropine Sulfate, USP 8 mg per
IPCA Dhar facility was inspected by USFDA in June 2023. The site (FEI 3007574780) was
FDA published the USFDA483 issued to Intas site (FEI 3003157498) in Ahmedabad, India after inspection
Strides recalled 2700 bottles of Losartan Potassium USP 25 mg tablets in US for presence
IPCA Ratlam (India) was issued USFDA 483 with 11 observations after inspection in June 2023
